IL17A and rheumatic heart disease: The proportion of IL-17-, IL-21-, IL-6-, and IL-23-positive cells in the RHD group was found to be dramatically higher compared to the degenerative valve disease control group, highlighting the critical role of these cytokines in RHD pathology.